0001209191-20-058450.txt : 20201116
0001209191-20-058450.hdr.sgml : 20201116
20201116160143
ACCESSION NUMBER: 0001209191-20-058450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201113
FILED AS OF DATE: 20201116
DATE AS OF CHANGE: 20201116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maloberti Renaud Bertrand
CENTRAL INDEX KEY: 0001744025
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37969
FILM NUMBER: 201316587
MAIL ADDRESS:
STREET 1: 10 ACORN WAY
CITY: GEORGETOWN
STATE: MA
ZIP: 01833
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDRA Life Sciences Inc.
CENTRAL INDEX KEY: 0001681682
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 260579295
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3600 GREEN COURT
STREET 2: SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
BUSINESS PHONE: 734-335-0468
MAIL ADDRESS:
STREET 1: 3600 GREEN COURT
STREET 2: SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
FORMER COMPANY:
FORMER CONFORMED NAME: Endra Inc.
DATE OF NAME CHANGE: 20160805
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-13
0
0001681682
ENDRA Life Sciences Inc.
NDRA
0001744025
Maloberti Renaud Bertrand
C/O ENDRA LIFE SCIENCES INC.
3600 GREEN COURT, SUITE 350
ANN ARBOR
MI
48105
0
1
0
0
Chief Commercial Officer
Common Stock
2020-11-13
4
S
0
10000
0.81
D
66580
D
Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.83, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Includes unvested restricted stock units.
/s/ Renaud B. Maloberti by Mark R. Busch, attorney-in-fact
2020-11-16